iohexol has been researched along with Shock, Cardiogenic in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzas-Mosquera, A | 1 |
| Vázquez-Rodríguez, JM | 1 |
| Calviño-Santos, R | 1 |
| Peteiro-Vázquez, J | 1 |
| Flores-Ríos, X | 1 |
| Marzoa-Rivas, R | 1 |
| Piñón-Esteban, P | 1 |
| Aldama-López, G | 1 |
| Salgado-Fernández, J | 1 |
| Vázquez-González, N | 1 |
| Castro-Beiras, A | 1 |
1 other study available for iohexol and Shock, Cardiogenic
| Article | Year |
|---|---|
[Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis].
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Cardiac Catheterization; Cohort Studies; Contrast Medi | 2007 |